Drug utilization studies: Their importance for post-marketing surveillance

被引：0
|
作者：
Castro, Lia C. [1 ]
机构：
[1] SOBRAVIME, Sao Paulo, Brazil
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2007年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
200
引用
收藏
页码：S95 / S96
页数：2
相关论文
共 50 条
  • [41] Post-marketing surveillance of escitalopram in depressed outpatients
    Möller, HJ
    Lotze, K
    Lange, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S428 - S428
  • [42] Challenges and perspectives in surveillance of post-marketing/use
    Fontenele Martins, Mary Anne
    Coelho Penna Teixeira, Ana Paula
    VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2019, 7 (04): : 3 - 9
  • [43] Characteristics of post-marketing studies and their contribution to post-marketing safety measures in Japan
    Kanmuri K.
    Narukawa M.
    Pharmaceutical Medicine, 2014, 28 (2) : 67 - 73
  • [44] A Clustering Ensemble Method for Drug Safety Signal Detection in Post-Marketing Surveillance
    Chakraborty, Shubhadeep
    Tiwari, Ram
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025, 59 (01) : 89 - 101
  • [45] Distributed, collaborative intelligent agents for proactive post-marketing drug safety surveillance
    Ji, Yanqing
    Ying, Hao
    Farber, Margo S.
    Yen, John
    Dews, Peter
    Miller, Richard E.
    Massanari, R. Michael
    NAFIPS 2007 - 2007 ANNUAL MEETING OF THE NORTH AMERICAN FUZZY INFORMATION PROCESSING SOCIETY, 2007, : 158 - +
  • [46] INFORMATION-SYSTEM FOR POST-MARKETING DRUG SURVEILLANCE SCHEME ON SMALL COMPUTERS
    MOUSSA, MAA
    METHODS OF INFORMATION IN MEDICINE, 1982, 21 (04) : 181 - 186
  • [47] Utility of electronic health records to support post-marketing drug safety surveillance
    Lin, Nancy D.
    Calderbank, Jenna
    Anderson, David
    Seeger, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 415 - 415
  • [48] Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
    Wakabayashi, Tomohito
    Nakatsuji, Takahiro
    Kambara, Hiroko
    Niinomi, Iku
    Oyama, Saki
    Inada, Ayaka
    Ueno, Sayaka
    Uchida, Mayako
    Iwanaga, Kazunori
    Iida, Tatsuya
    Hosohata, Keiko
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2022, 17 (02) : 144 - 148
  • [49] A Temporal Interestingness Measure for Drug Interaction Signal Detection in Post-marketing Surveillance
    Ji, Yanqing
    Ying, Hao
    Tran, John
    Dews, Peter
    Mansour, Ayman
    Massanari, R. Michael
    2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2014, : 2722 - 2725
  • [50] Post-marketing surveillance of escitalopram in depressed outpatients
    Moeller, H.-J.
    Lotze, K.
    Langer, S.
    Montgomery, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S259 - S259
12345